GC
CVS icon

Globeflex Capital’s CVS Health CVS Stock Holding History

Globeflex Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-242,328
Closed -$19.3M – 479
2024
Q1 		$19.3M Hold
242,328
– – 1.88% 7
2023
Q4 		$19.1M Sell
242,328
-53
-0% -$3.77K 1.95% 8
2023
Q3 		$16.9M Hold
242,381
– – 1.98% 6
2023
Q2 		$16.8M Hold
242,381
– – 1.87% 6
2023
Q1 		$18M Hold
242,381
– – 2.2% 6
2022
Q4 		$22.6M Buy
242,381
+128,000
+112% +$12.4M 2.86% 5
2022
Q3 		$10.9M Buy
114,381
+114,328
+215,713% +$11.3M 1.87% 4
2022
Q2 		$5K Hold
53
– – ﹤0.01% 434
2022
Q1 		$5K Hold
53
– – ﹤0.01% 434
2021
Q4 		$5K Buy
+53
New +$4.9K ﹤0.01% 427
2013
Q3 		– Sell
-45
Closed -$2K – 620
2013
Q2 		$2K Buy
+45
New +$2.61K ﹤0.01% 423

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Globeflex Capital's CVS Position: Q2 2024 in Review

Globeflex Capital sold out of CVS Health (CVS) in Q2 2024, closing a stake of 242,328 shares — an estimated $19.3M sold.

Globeflex Capital first reported a position in CVS in Q2 2013 and held it in 11 quarters. The position peaked at $22.6M in Q4 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Globeflex Capital reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Globeflex Capital sold 242,328 CVS Health shares in Q2 2024, an estimated $19.3M.
  • Globeflex Capital first reported a position in CVS Health in Q2 2013 and held it in 11 quarters.
  • Globeflex Capital's CVS Health position peaked at $22.6M in Q4 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Globeflex Capital's 13F filing for Q2 2024, filed 13 Aug 2024.